239 related articles for article (PubMed ID: 18789487)
21. Genomic landscapes of breast fibroepithelial tumors.
Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT
Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships.
Park KH; Choi SE; Eom M; Kang Y
Breast Cancer Res; 2005; 7(2):R238-47. PubMed ID: 15743504
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
Moore T; Lee AH
Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
[TBL] [Abstract][Full Text] [Related]
24. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
25. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
[TBL] [Abstract][Full Text] [Related]
26. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
27. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
[TBL] [Abstract][Full Text] [Related]
29. Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor.
Hodges KB; Abdul-Karim FW; Wang M; Lopez-Beltran A; Montironi R; Easley S; Zhang S; Wang N; MacLennan GT; Cheng L
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):345-50. PubMed ID: 19276971
[TBL] [Abstract][Full Text] [Related]
30. Sonographic features of phyllodes tumors of the breast.
Chao TC; Lo YF; Chen SC; Chen MF
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):64-71. PubMed ID: 12100421
[TBL] [Abstract][Full Text] [Related]
31. p53 protein expression and gene mutation in phyllodes tumors of the breast.
Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
[TBL] [Abstract][Full Text] [Related]
32. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
[TBL] [Abstract][Full Text] [Related]
33. Clonal analysis of fibroadenoma and phyllodes tumor of the breast.
Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer Res; 1993 Sep; 53(17):4071-4. PubMed ID: 8395336
[TBL] [Abstract][Full Text] [Related]
34. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
Maritz RM; Michelow PM
Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
[TBL] [Abstract][Full Text] [Related]
35. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant.
Hasebe T; Imoto S; Sasaki S; Tsubono Y; Mukai K
Pathol Int; 1999 May; 49(5):435-43. PubMed ID: 10417687
[TBL] [Abstract][Full Text] [Related]
36. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract][Full Text] [Related]
37. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
[TBL] [Abstract][Full Text] [Related]
38. "Missed" diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition.
Yohe S; Yeh IT
Int J Surg Pathol; 2008 Apr; 16(2):137-42. PubMed ID: 18417670
[TBL] [Abstract][Full Text] [Related]
39. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
